Commodore Capital Lp

13F Holdings History for SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Symbol: SABS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 4.52M shares
Security Ownership: 9.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Commodore Capital LP ownership in SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS)

2025-10-03 - Commodore Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.52M shares of SAB Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (SABS). This represents 9.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Commodore Capital LP	9.9%		$9.59M	4.52M			$2.12	13G	9/26/2025	3 Oct 2025 16:05:22

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2024		-0.06%	$0	0	-183,174	-100%		Q2 2024
3/31/2024	0.06%	-0.65%	$832K	183K	-1,648,572	-90%	$4.54	Q1 2024
12/31/2023	0.11%	+0.15%	$1.26M	1.83M	+1,831,746	NEW	$0.69	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.